Years of violence and weak institutions meant most of the sectors in the country are in bad shape. Pharma sector suffers from insufficient investment, lack of a quality testing agency, and bad inadequate enforcement of rules. The country has a significant cost advantage in terms of favorable terms of trade and cheap labor. But it needs to work on the areas of investment and creating a trained workforce to turn this weakness into opportunity.